Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03006237 · ClinicalTrials.gov registry record · Phase 1
IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics
A Phase 1 study, sponsored by Intuitive Surgical.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT03006237: Completed Phase 1 study, sponsored by Intuitive Surgical.
NCT03006237 is a Phase 1 study that has completed, run by Intuitive Surgical. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03006237, a Phase 1 study, has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
A Phase 1 Open Label Single Center Safety, Tolerability and Pharmacokinetic Study of IS-001
Primary Outcome
Vital signs, 12-lead ECG, serum chemistry (CMP) and hematology (CBC), urinalysis and incidence of treatment-emergent adverse events
Interventions
- DRUG IS-001
- DEVICE da Vinci® Si/Xi Surgical System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-12 |
| Est. Completion | 2017-12 |
| Phase | Phase 1 |
What the finished NCT03006237 record still lists
NCT03006237 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which IS-001 is the first listed.
NCT03006237 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03006237 about?
NCT03006237 is a clinical study titled "IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics". A Phase 1 Open Label Single Center Safety, Tolerability and Pharmacokinetic Study of IS-001
What is the current status of trial NCT03006237?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2016-12. Estimated completion is 2017-12.
What interventions are being tested in trial NCT03006237?
The interventions under investigation include: IS-001 (DRUG), da Vinci® Si/Xi Surgical System (DEVICE).
Who is sponsoring clinical trial NCT03006237?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03006237's enrollment target sits among peer trials
24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia